Range
- - -
Vol / Avg.
-/1.4M
Div / Yield
-
52 Wk
67.38 - 220.2
Mkt Cap
10.4B
Payout Ratio
-
Open
-
P/E
-
EPS
-1.51
Shares
80.3M
Outstanding
80.3M
Total Float
56.5M
load more
CRISPR Therapeutics AG is a gene-editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 is a technology that allows for precise, directed changes to genomic DNA. The company advanced programs target beta-thalassemia and sickle cell disease, two hemoglobinopathies that have a high unmet medical need.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-07-26
REV
Q1 2021Est.ActualSurprise
EPS-1.470-1.510 -0.0400
REV1.140M539.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CRSPCRISPR Therapeutics0%10.4B

CRISPR Therapeutics Frequently Asked Questions

Q

How do I buy CRISPR Therapeutics (CRSP) stock?

A

You can purchase shares of CRISPR Therapeutics (NASDAQ: CRSP) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are CRISPR Therapeutics's (CRSP) competitors?

A

There are no as such competitors for CRISPR Therapeutics.

Q

What is the target price for CRISPR Therapeutics (CRSP) stock?

A

The latest price target for CRISPR Therapeutics (NASDAQ: CRSP) was reported by Citigroup on June 14, 2021. The analyst firm set a price target for 132.00 expecting CRSP to rise to within 12 months (a possible 1.84% upside). 18 analyst firms have reported ratings in the last year.

Q

Current Stock Price for CRISPR Therapeutics (CRSP)?

A

The stock price for CRISPR Therapeutics (NASDAQ: CRSP) is $129.62 last updated Mon Jun 21 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does CRISPR Therapeutics (CRSP) pay a dividend?

A

There are no upcoming dividends for CRISPR Therapeutics.

Q

When is CRISPR Therapeutics (NASDAQ:CRSP) reporting earnings?

A
CRISPR Therapeutics’s Q2 earnings are confirmed for after-market on July 26, 2021.
Q

Is CRISPR Therapeutics (CRSP) going to split?

A

There is no upcoming split for CRISPR Therapeutics.

Q

What sector and industry does CRISPR Therapeutics (CRSP) operate in?

A

CRISPR Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.